Impact of oxidative/nitrosative stress and inflammation on cognitive functions in patients with recurrent depressive disorders

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 110-115

  Talarowska, Monika ^a   Bobińska, Kinga ^a   Zajaczkowska, Marlena ^a   Su, Kuan Pin ^b   Maes, Michael ^c,d   Gałecki, Piotr ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c DEAKIN UNIVERSITY   (Australia)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Cognitive functions; Inflammation; Oxidative and nitrosative stress; Recurrent depressive disorders

Indexed keywords

ALPHA INTERFERON; CYCLOOXYGENASE 2; GAMMA INTERFERON; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; LIPID; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MYELOPEROXIDASE; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TAU PROTEIN; UNSATURATED FATTY ACID; PEROXIDASE; SUPEROXIDE DISMUTASE;

ANXIETY DISORDER; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; COGNITION; DEGENERATIVE DISEASE; DEPRESSION; ENZYME ACTIVITY; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECURRENT DISEASE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WORKING MEMORY; EUROPE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

COGNITION; DEPRESSIVE DISORDER; EUROPE; HUMANS; INFLAMMATION; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PEROXIDASE; REACTIVE NITROGEN SPECIES; RECURRENCE; SUPEROXIDE DISMUTASE;

EID: 84896720144     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.889853     Document Type: Review

References (75)

1. Wittchen HU, Jacobi F, Rehm J et al: The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharm, 2011; 21: 655-59
2. Reynolds CF III, Cuijpers P, Patel V et al: Early intervention to reduce the global health and economic burden of major depression in older adults. Annu Rev Public Health, 2012; 33: 123-25
3. Gosek P, Chojnacka M, Bieńskowski P, Świe{ogonek}cicki Ł: Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression. Psych Pol, 2012; XLVI: 283-94
4. Mead GE, Morley W, Campbell P et al: Exercise for depression. Cochrane Database Syst Rev, 2008; 4: CD004366
5. Richardson R, Richards DA, Barkham M: Self-help books for people with depression: a scoping review. J Ment Health, 2008; 17: 543-52
6. Maes M, Galecki P, Chang YS, Berk M: A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry, 2011; 35(3): 676-92
7. Sivonova M, Zitnanova I, Hlincikova L et al: Oxidative stress in university students during examinations. Stress, 2004; 7(3): 183-88
8. Alexopoulos GS, Morimoto SS: The inflammation hypothesis in geriatric depression. Int J Geriatr Psychiatry. Int J Geriatr Psychiatry, 2011; 26(11): 1109-18
9. Lu DY, Leung YM, Su KP: Interferon-a induces nitric oxide synthase expression and haem oxygenase-1 down-regulation in microglia: implications of cellular mechanism of IFN-a-induced depression. Int J Neuropsychopharmacol, 2013; 16(2): 433-44
10. Su KP: Inflammation in psychopathology of depression: Clinical, biological and therapeutic implications. BioMedicine, 2012; 68-74
11. Canon ME, Crimmins EM: Sex differences in the association between muscle quality, inflammatory markers, and cognitive decline. J Nutr Health Aging, 2011; 15: 695-98
12. Insel KC, Moore IM, Vidrine AN, Montgomery DW: Biomarkers for cognitive aging-part II: oxidative stress, cognitive assessments, and medication adherence. Biol Res Nurs, 2012; 14(2): 133-38
13. Maes M, Berk M, Goehler L et al: Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med, 2012; 10: 66
14. Sarandol A, Sarandol E, Eker SS et al: Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol, 2007; 22: 67-73
15. Hassin-Baer S, Cohen OS, Vakil E et al: Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease? J Neural Transm, 2011; 118(4): 539-43
16. Radwańska-Wala B, Buszman E, Drużba D: Udział reaktywnych form tlenu w patogenezie chorób ośrodkowego układu nerwowego. Wiad Lek, 2008; LXI: 1-3 [in Polish]
17. Padurariu M, Ciobica A, Hritcu L et al: Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett, 2010; 469(1): 6-10
18. Talarowska M, Gałecki P, Maes M et al: Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder. Mol Biol Rep, 2012; 39(5): 5359-66
19. Talarowska M, Gałecki P, Maes M et al: Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder. Neurosci Lett, 2012; 510(2): 127-31
20. Talarowska M, Gałecki P, Maes M et al: Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder. Neurochem Res, 2012; 37(8): 1761-67
21. Behr GA, Moreira JC, Frey BN: Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxid Med Cell Longev, 2012; 2012: 609421
22. Vaccarino V, Brennan ML, Miller AH et al: Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry, 2008; 64: 476-83
23. Wang D, An SC, Zhang X: Prevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor. Neurosci Lett, 2008; 433: 59-64
24. Valko M, Leibfritz D, Moncol J et al: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol, 2007; 39(1): 44-84
25. Catena-Dell'Osso M, Bellantuono C, Consoli G et al: Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Curr Med Chem, 2011; 18(2): 245-55
26. Lu DY, Tsao YY, Leung YM, Su KP: Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for w-3 fatty acids. Neuropsychopharmacol, 2010; 35(11): 2238-48
27. Su KP, Huang SY, Peng CY et al: Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol Psychiatry, 2010; 67(6): 550-57
28. Long JA, Fogel-Petrovic M, Knight DA et al: Higher prostaglandin e2 production by dendritic cells from subjects with asthma compared with normal subjects. Am J Respir Crit Care Med, 2004; 170: 485-91
29. El Sayed NS, Kassem LA, Heikal OA: Promising therapy for Alzheimer's disease targeting angiotensinconverting enzyme and the cyclooxygense-2 isoform. Drug Discov Ther, 2009; 3(6): 307-15
30. Maki RA, Tyurin VA, Lyon RC et al: Aberrant expression ofmyeloperoxidase in astrocytes promotes phospholipid oxidation andmemory deficits in amousemodel of Alzheimer disease. J Biol Chem, 2009; 284: 3158-69
31. Gray E, Thomas TL, Betmouni S et al: Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol, 2008; 18: 86-95
32. Ekmekci OB, Donma O, Sardoǧan E et al: Iron, nitric oxide, and myeloperoxidase in asthmatic patients. Biochem, 2004; 69: 462-67
33. Redington AE, Meng QH, Springall DR et al: Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax, 2001; 56: 351-57
34. Müller GJ, Lassmann H, Johansen FF: Anti-apoptotic signaling and failure of apoptosis in the ischemic rat hippocampus. Neurobiol Dis, 2007; 25: 582-93
35. Radenović L, Selaković V, Kartelija G: Mitochondrial superoxide production and MnSOD activity after exposure to agonist and antagonists of ionotropic glutamate receptors in hippocampus. Ann NY Acad Sci, 2005; 1048: 363-65
36. Li Y, Huang TT, Carlson EJ et al: Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet, 1995; 11(4): 376-81
37. Herken H, Gurel A, Selek S et al: Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res, 2007; 38(2): 247-52
38. Selek S, Savas AH, Gergerlioglu HS et al: The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord, 2008; 107(1-3): 89-94
39. Gałecki P, Szemraj J, Bieńkiewicz M et al: Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol Rep, 2009; 61(3): 436-47
40. Pietras T, Witusik A, Panek M et al: Anxiety, depression and polymorphism of the gene encoding superoxide dismutase in patients with chronic obstructive pulmonary disease. Pol Merk Lek, 2010; 29(171): 165-68
41. Herring A, Blome M, Ambrée O et al: Reduction of cerebral oxidative stress following environmental enrichment in mice with Alzheimer-like pathology. Brain Pathol, 2010; 20(1): 166-75
42. Michel TM, Frangou S, Thiemeyer D et al: Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder-a postmortem study. Psych Res, 2007; 151: 145-50
43. Hu D, Cao P, Thiels E et al: Hippocampal long-term potentiation, memory, and longevity in mice that overexpress mitochondrial superoxide dismutase. Neurobiol Learn Mem, 2007; 87: 372-84
44. Soerensen M, Christensen K, Stevnsner T, Christiansen L: The Mn-superoxide dismutase single nucleotide polymorphism rs4880 and the glutathione peroxidase 1 single nucleotide polymorphism rs1050450 are associated with aging and longevity in the oldest old. Mech Ageing Dev, 2009; 130(5): 308-14
45. Dumont M, Wille E, Stack C et al: Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J, 2009; 23(8): 2459-66
46. Li F, Calingasan NY, Yu F et al: Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem, 2004; 89: 1308-12
47. Melov S, Adlard PA, Morten K et al: Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE, 2007; 2: e536
48. Esposito L, Raber J, Kekonius L et al: Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci, 2006; 26: 5167-79
49. Gałecki P, Maes M, Florkowski A et al: An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder. J Neurosci Lett, 2010; 486(3): 184-87
50. Gałecki P, Maes M, Florkowski A et al: Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. J Affect Disord, 2011; 129: 175-82
51. Ankarali S, Ankarali HC, Marangoz C: Further evidence for the role of nitric oxide in maternal aggression: effects of L-NAME on maternal aggression towards female intruders in Wistar rats. Physiol Res, 2009; 58(4): 591-98
52. Calabrese V, Mancuso C, Calvani M et al: Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci, 2007; 8: 766-75
53. Chrapko WE, Jurasz P, Radomski MW et al: Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol Psychiatry, 2004; 56(2): 129-34
54. Aktan F: iNOS-mediated nitric oxide production and its regulation. Life Sci, 2004; 75: 639-53
55. Madrigal JL, Moro MA, Lizasoain I et al: Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J Neurochem, 2001; 76: 532-38
56. Gałecki P, Gałecka E, Maes M et al: The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder. J Affect Disord, 2012; 138(3): 360-66
57. Kim YK, Paik JW, Lee SW et al: Increased plasma nitric oxide level associated with suicide attempt in depressive patients. Prog Neuropsychopharmacol Biol Psychiatry, 2006; 30(6): 1091-96
58. Maes M, Mihaylova I, Kubera M et al: IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology. J Affect Disord, 2011; 135(1-3): 414-18
59. Maes M, Kubera M, Mihaylova I et al: Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression. J Affect Disord, 2013; 149(1-3): 23-29
60. McCann SM: The nitric oxide hypothesis of aging. Exp Gerontol, 1997; 32(4-5): 431-40
61. Oliveira RM, Guimarães FS, Deakin JF: Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Braz J Med Biol Res, 2008; 41(4): 333-41
62. Blanco S, Molina FJ, Castro L et al: Study of the nitric oxide system in the rat cerebellum during aging. BMC Neurosci, 2010; 11: 78
63. Johnson KA, Conn PJ, Niswender CM: Glutamate receptors as therapeutic targets for Parkinson's disease. CNS Neurol Disord Drug Targets, 2009; 8: 475-91
64. Tseng IJ, Liu HC, Yuan RY et al: Expression of inducible nitric oxide synthase (iNOS) and period 1 (PER1) clock gene products in different sleep stages of patients with cognitive impairment. J Clin Neurosci, 2010; 17(9): 1140-43
65. Eckel B, Ohl F, Bogdanski R et al: Cognitive deficits after systemic induction of inducible nitric oxide synthase: a randomised trial in rats. Eur J Anaesthesiol, 2011; 28(9): 655-63
66. Gökçek-Saraç C, Karakurt S, Adali{dotless} O, Jakubowska-Doǧru E: Correlation between hippocampal levels of neural, epithelial and inducible NOS and spatial learning skills in rats. Behav Brain Res, 2012; 235(2): 326-33
67. Xu J, Rong S, Xie B et al: Changes in the nitric oxide system contribute to effect of procyanidins extracted from the lotus seedpod ameliorating memory impairment in cognitively impaired aged rats. Rejuvenation Res, 2011; 14(1): 33-43
68. Hritcu L, Ciobica A, Stefan M et al: Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease. Neurosci Res, 2011; 71(1): 35-43
69. Gałecki P, Florkowski A, Bobińska K et al: Functional polymorphismof the myeloperoxidase gene (G-463A) in depressive patients. Acta Neuropsychiatr, 2010; 5: 218-22
70. Meuwese MC, Stroes ES, Hazen SL et al: Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol, 2007; 50: 159-65
71. Gałecki P, Talarowska M, Moczulski D et al: Working memory impairment as a common component in recurrent depressive disorder and certain somatic diseases. Neuro Endocrinol Lett, 2013; 34(5): 436-45
72. Mann I, Valentino P, La Russa A et al: Genetic variation in the myeloperoxidase gene and cognitive impairment in multiple sclerosis. J Negat Results Biomed, 2006; 5: 3
73. Pope SK, Kritchevsky SB, Ambrosone C et al: Myeloperoxidase polymorphism and cognitive decline in older adults in the Health, Aging, and Body Composition Study. Am J Epidemiol, 2006; 163(12): 1084-90
74. Lefkowitz DL, Lefkowitz SS: Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease. Free Radic Biol Med, 2008; 45: 726-31
75. Beer C, Blacker D, Hankey GJ, Puddey IB: Association of clinical and aetiologic subtype of acute ischaemic stroke with inflammation, oxidative stress and vascular function: A cross-sectional observational study. Med Sci Monit, 2011; 17(9): CR467-73